ApprovalTrail

Natural health product · NPN 80026312

Joint Essentials

Yes: licensed in Canada

The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.

Licence status Active; licensed July 11, 2011; licence last revised May 21, 2021.
Natural Product Number (NPN)
80026312
Dosage form
Capsule
Route
Oral
Licensing route
Non-Traditional
First licensed
July 11, 2011
Licence last revised
May 21, 2021

Also sold as

Other product names on the same licence.

  • Joint Essentials Plus

Medicinal ingredients

Per dosage unit, as licensed.

IngredientAmount
Partially hydrolysed chicken eggshell membrane125 mg
Curcuminoids95 mg
2-amino-2-deoxy-D-glucose sulfate375 mg
2-amino-2-deoxy-D-glucose sulfate375 mg

What it is licensed for

The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.

  • Helps to relieve joint pain associated with osteoarthritis. Helps to relieve joint pain associated with osteoarthritis of the knee. Helps to protect against the deterioration of cartilage. A factor in maintaining healthy cartilage and/or joint health. Helps reduce joint stiffness associated with osteoarthritis. Clinically proven to help reduce joint pain in 7-10 days. Helps to relieve joint pain associated with osteoarthritis of the knee. Helps to relieve joint pain and stiffness associated with osteoarthritis. Helps to reduce joint pain and stiffness. Research-proven to help reduce joint pain in 7-10 days. Starts to help reduce pain and increase joint flexibility at 7 days. Helps relieve joint pain in 7-10 days. Helps to relieve pain associated with osteoarthritis of the knee. Helps to relieve/reduce joint pain associated with osteoarthritis. Helps to minimize discomfort due to moderate intensity aerobic exercise in post-menopausal women. Helps to improve recovery from joint pain and stiffness due to moderate intensity aerobic exercise in post-menopausal women. Helps reduce levels of CTX-II, a biomarker/marker of cartilage degradation due to moderate intensity aerobic exercise in post-menopausal women. Helps reduce levels of CTX-II, a biomarker/marker of joint degradation due to moderate intensity aerobic exercise in post-menopausal women.

Non-medicinal ingredients

Magnesium Stearate; Gelatin; Cellulose; Purified water